MMJ Group Holdings Limited (MMJ) owns a portfolio of cannabis sector investments.
MMJ aims to invest across the full range of cannabis-related sectors including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, R&D and retail.
Latest Media Releases
18/01/2021 08:21:00
MMJ Group Holdings Limited (ASX:MMJ) ("MMJ"), is an Australian listed company whose core business is holding minority investments along the cannabis value-chain in Australia, Canada and Eu…
11/12/2020 10:13:00
MMJ Group Holdings Limited (ASX:MMJ) ("MMJ"), is an Australian listed company whose core business is holding minority investments along the cannabis value-chain in Australia, Canada and Eu…
Latest News
Company Presentations /
by -
29 days ago
21 Dec 2020 - MMJ Group Holdings Limited (ASX:MMJ) presents an update on the company. Speakers are Mike Curtis, MMJ Non-Executive Director and Director of Embark Ventures Inc, the …
Company Presentations /
by -
3 months ago
03 Oct 2020 - MMJ Group Holdings Limited (ASX:MMJ) presents an update on the company. Speakers are Mike Curtis, MMJ Non-Executive Director and Director of Embark Ventures Inc, the …
Company Presentations /
by -
6 months ago
17 July 2020 - MMJ Group Holdings Limited (ASX:MMJ) presents an update on the company. Speakers: Mike Curtis, Non-Executive Director of MMJ and Director of Embark Ventures Inc, the…
Company Presentations /
by -
8 months ago
23 Apr 2020 - MMJ Group Holdings Limited (ASX:MMJ) presents an update on the company. Speakers are Mike Curtis, MMJ Non-Executive Director and Director of Embark Ventures Inc, the …
Interviews /
by Rachael Jones -
11 months ago
03 Feb 2020 - Embark Ventures Managing Partner Michael Curtis provides an update on talks about the company's role as investment manager for MMJ Group Holdings (ASX:MMJ), the Canad…
Company Presentations /
by -
A year ago
24 Jul 2019 - MMJ Group Holdings Limited (ASX:MMJ) Non-Executive Director Michael Curtis provides an investor update.
Interviews /
by Rachael Jones -
A year ago
17 Jul 2019 - Embark Ventures Managing Partner Michael Curtis talks about the company's role as the investment manager for MMJ Group Holdings (ASX:MMJ), and the Canadian and broade…
Company Presentations /
by -
A year ago
05 Jun 2019 - MMJ Group Holdings Limited (ASX:MMJ) CFO, Jim Hallam presents on the company's cannabis investments, how MMJ sources early stage opportunities, its connections in Can…
Interviews /
by Anna Napoli -
A year ago
03 Jun 2019 - MMJ Group Holdings Limited (ASX:MMJ) CFO, Jim Hallam provides an overview of the company's investments, the sourcing of early stage opportunities, its connections in …
Interviews /
by Jessica Amir -
A year ago
07 May 2019 - MMJ Group Holdings (ASX.MMJ) CFO, Jim Hallam provides an overview of its investments and talks about growth in the sector as medicinal and recreational use becomes le…
Company News /
by Katrina Bullock -
A year ago
08 Feb 2019 - Global cannabis investment company, MMJ Group Holdings (ASX:MMJ) have announced that one of their investments, MediPharm Labs, has changed management.
Market Reports /
by Rachael Jones -
2 years ago
11 Jan 2019 - The ASX took a downward slide after lunch, closing 0.4% lower. The materials sector weighed heavy on the index. Regis Resources (ASX:RRL) was the worst performing sto…
Company News /
by Rachael Jones -
2 years ago
11 Jan 2019 - MMJ Group Holdings (ASX:MMJ) says MediPharm Labs is already replenishing and increasing inventory to ensure uninterrupted cannabis oil supply for its existing custome…
Company News /
by Anna Napoli -
2 years ago
09 Jan 2019 - Cannabis investment company, MMJ Group Holdings (ASX:MMJ) has announced the appointment of Michael Curtis as a non-executive director.
Company News /
by Rachael Jones -
2 years ago
31 Dec 2018 - Cannabis investment company MMJ Group Holdings (ASX:MMJ) is pleased to announce that MediPharm Labs has been added to the Horizons Marijuana Life Sciences Index ETF.
Market Reports /
by Jessica Amir -
2 years ago
27 Dec 2018 - Mid session report. Oil gains 10%. Bellamy's Australia (ASX:BAL) shares bounce 5% higher. Afterpay Touch Group (ASX:APT) shares rally up 5% on boxing day sales. MMJ …
Market Reports /
by Jessica Amir -
2 years ago
11 Oct 2018 - ASX down 1.9% mid-session on US equity market sell-off. Gold stocks rally, St Barbara up 4%. Harvey Norman Holdings goes ex-div. Netwealth funds hit $19.3b. MMJ's par…
Market Reports /
by Jessica Amir -
2 years ago
08 Jun 2018 - Market Wrap. ASX20, ASX50, ASX100 and ASX200 reshuffled with Afterpay Touch (ASX:APT) & Kidman Resources (ASX:KDR) in ASX200. MMJ PhyoTech (ASX:MMJ) pleased Canada cl…
Company News /
by Anna Napoli -
2 years ago
10 Apr 2018 - Medical Canabis company, MMJ Phytotech (ASX:MMJ) has invested $1 million dollars for a 16.7 per cent ownership stake in Biologics Research Institute Australia.
Company Presentations /
by -
2 years ago
05 Mar 2018 - MMJ Phytotech (ASX:MMJ) CEO Jason Conroy provides an update on the company's investment portfolio, key holding in Canadian Harvest One Cannabis and regulatory change.
Interviews /
by Jessica Amir -
2 years ago
27 Feb 2018 - MMJ Phytotech Limited (ASX:MMJ) CEO Jason Conroy provides an update on the company's investment portfolio, key holding in Canadian Harvest One Cannabis and regulatory…
Market Reports /
by Jessica Ellerm -
3 years ago
10 Jan 2018 - Streak could be snapped: Aus shares 0.17% lower at noon. MMJ PhytoTech Limited (ASX:MMJ) announces Canadian based subsidiary Harvest One Cannabis intends to raise up …
Company News /
by Jessica Ellerm -
3 years ago
29 Dec 2017 - MMJ PhytoTech Limited (ASX:MMJ) announces it is in the final stages of subscribing to C$2 million in secured convertible debentures in Toronto based Weed Me Inc.
Company News /
by Kathy Skantzos -
3 years ago
01 Dec 2017 - Medicinal cannabis producer MMJ PhytoTech (ASX:MMJ) announces the Chief Executive Officer of its 100 per cent owned Israeli-based subsidiary PhytoTech Therapeutics, D…
Company News /
by Liz Pal -
3 years ago
05 Oct 2017 - MMJ PhytoTech (ASX:MMJ) has announced Harvest One Cannabis operation update on Satipharm. Key updates include the receipt of a German ‘Free Sales Certificate.’
